Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119259) titled 'Development and Application of an Artificial Intelligence Prediction Model for Postoperative Tumor Recurrence in Patients Undergoing Surgical Treatment for Hilar Cholangiocarcinoma Based on Multimodal Big Data' on Feb. 25.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: The First Affiliated Hospital of Army Medical University
Condition:
Hilar cholangiocarcinoma
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-25
Target Sample Size: Observation group of hilar cholangiocarcinoma:608;
Countries of Recruitment:
China
To know more, visit https://...